WTIM
REGN icon

Wilmington Trust Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Wilmington Trust Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$508K Sell
1,800
-200
-10% -$59.3K 0.1% 150
2014
Q1 		$601K Buy
2,000
+400
+25% +$123K 0.12% 123
2013
Q4 		$440K Hold
1,600
– – 0.09% 201
2013
Q3 		$501K Hold
1,600
– – 0.1% 159
2013
Q2 		$360K Buy
+1,600
New +$373K 0.08% 235

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wilmington Trust Investment Management's REGN Position: Q2 2014 in Review

Wilmington Trust Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 10% in Q2 2014, selling an estimated $59.3K and leaving 1,800 shares worth $508K. The position accounts for 0.1% of the portfolio, ranked #150.

Wilmington Trust Investment Management first reported a position in REGN in Q2 2013 and has held it in 5 quarters since. The position peaked at $601K in Q1 2014. 448 funds tracked by Wall St. Rank hold REGN as of Q2 2014.

  • Wilmington Trust Investment Management held 1,800 shares of Regeneron Pharmaceuticals worth $508K as of Q2 2014.
  • Wilmington Trust Investment Management sold 200 Regeneron Pharmaceuticals shares in Q2 2014, an estimated $59.3K.
  • Regeneron Pharmaceuticals made up 0.1% of Wilmington Trust Investment Management's portfolio in Q2 2014, its #150 holding.
  • Wilmington Trust Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Trust Investment Management's Regeneron Pharmaceuticals position peaked at $601K in Q1 2014.
  • 448 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2014.

Based on Wilmington Trust Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.